Inventor
TAO ZHI-FU
US47 patents
⚠️ This page may combine multiple inventors who share the name “TAO ZHI-FU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
30 patentsUS9174982B2Nov 3, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC38 citations98
US9045475B2Jun 2, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC14 citations93
US9315488B2Apr 19, 2016
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC13 citations92
US9029404B2May 12, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC19 citations92
US8952157B2Feb 10, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC22 citations91
US9303025B2Apr 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC11 citations84
US9125913B2Sep 8, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC10 citations84
US9072748B2Jul 7, 2015
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9073855B2Jul 7, 2015
BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9045420B2Jun 2, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9034875B2May 19, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC19 citations84
US8883784B2Nov 11, 2014
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC11 citations84
US9403822B2Aug 2, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC9 citations83
US8940737B2Jan 27, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC7 citations83
US10676485B2Jun 9, 2020
Macrocyclic MCL-1 inhibitors and methods of use
ABBVIE INC2 citations73
US11897864B2Feb 13, 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US11786519B2Oct 17, 2023
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US9844547B2Dec 19, 2017
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC1 citations62
US9266877B2Feb 23, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC2 citations62
US9227963B2Jan 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC2 citations62
US8889675B2Nov 18, 2014
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC3 citations62
US9650358B2May 16, 2017
Pyridine CDK9 kinase inhibitors
ABBVIE INC1 citations52
US9359296B2Jun 7, 2016
7-substituted indole Mcl-1 inhibitors
ABBVIE INC1 citations52
US9035047B2May 19, 2015
7-substituted indole Mcl-1 inhibitors
ABBVIE INC1 citations52
US9877958B2Jan 30, 2018
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC1 citations51
US8969375B2Mar 3, 2015
CDK9 kinase inhibitors
ABBVIE INC2 citations51
US10081628B2Sep 25, 2018
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations50
US9346813B2May 24, 2016
Substituted pyrrolo[2,3-d]pyrimindines as CDK9 kinase inhibitors
ABBVIE INC0 citations41
US9073922B2Jul 7, 2015
Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors
ABBVIE INC0 citations40
US9796708B2Oct 24, 2017
Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors
ABBVIE INC0 citations36
ABBOTT LAB
4 patentsUS7981888B2Jul 19, 2011
1-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives
ABBOTT LAB8 citations84
US7956185B2Jun 7, 2011
Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases
ABBOTT LAB5 citations61
US7320986B2Jan 22, 2008
Fused tri and tetra-cyclic pyrazole kinase inhibitors
ABBOTT LAB0 citations40
US7163939B2Jan 16, 2007
Macrocyclic kinase inhibitors
ABBOTT LAB0 citations39
BRUNCKO MILAN
3 patentsUS8586754B2Nov 19, 2013
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN59 citations97
US8563735B2Oct 22, 2013
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN72 citations97
US8546399B2Oct 1, 2013
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
BRUNCKO MILAN100 citations97